Skip to main content

Table 2 Functional characteristics of the 30 CF children

From: Beneficial short-term effect of autogenic drainage on peripheral resistance in childhood cystic fibrosis disease

Characteristics

With bronchial congestion

Without bronchial congestion

After versus before AD, all patients

After salbutamol versus before all patients

Between 2 groups (with and without) at baseline

N = 10

N = 20

Lung function

Before AD

After AD

After salbutamol

Before AD

After AD

After salbutamol

VD, cm3

80 [71; 112]

90 [75; 104]

ND

76 [44; 121]

85 [55; 120]

ND

0.097

 

0.509

VD/height, cm2

0.53 [0.46; 0.70]

0.61 [0.55; 0.66]

ND

0.53 [0.37; 0.70]

0.60 [0.41; 0.75]

ND

0.098

 

0.660

Spirometry, patients, n

 

10

7

 

17

7

   

FEV1, L

ND

1.66 [1.14; 2.32]

1.87 [1.38; 2.42]

ND

2.01 [1.56; 2.59]

1.81 [0.97; 2.49]

 

0.007

 

FEV1, z-score

ND

 − 2.49 [− 3.51; − 2.09]

 − 2.30 [− 3.47; − 1.80]

ND

 − 0.72 [− 2.41; 0.14]$

 − 2.38 [− 3.89; − 2.25]

   

FVC, L

ND

2.33 [1.55; 3.31]

2.38 [1.89; 3.35]

ND

2.73 [1.97; 3.54]

2.51 [1.77; 3.47]

 

0.195

 

FVC, z-score

ND

 − 1.53 [− 2.66; − 0.35]

 − 1.18 [− 2.34; − 1.11]

ND

 − 0.16 [− 1.52; 0.48]

 − 1.54 [− 2.03; − 0.35]

   

FEV1/FVC

ND

0.75 [0.70; 0.77]

0.78 [0.72; 0.79]

ND

0.81 [0.70; 0.83]

0.69 [0.59; 0.76]

 

0.064

 

FEV1/FVC, z-score

ND

 − 2.08 [− 2.53; − 1.44]

 − 1.84 [− 2.31; − 1.68]

ND

 − 1.04 [− 2.31; − 0.84]

 − 2.39 [− 3.48; − 1.49]

   

IOS, patients, n

10

10

10

20

20

20

   

Fres, Hz

20.97 [14.34; 23.93]

18.82 [13.88; 26.12]

11.9 [11.2; 25.3]

19.21 [13.76; 25.13]

18.99 [14.74; 22.95]

18.3 [14.5; 25.5]

0.943

0.016

 

Fres, z-score

0.85 [− 0.70; 1.02]

0.54 [− 0.87; 2.61]

 − 0.90 [− 3.79; 2.35]

0.46 [− 1.01; 1.89]

0.18 [− 0.87; 0.96]

0.17 [− 0.84; 1.12]

  

0.481

R20Hz, kPa/L/s

0.47 [0.31; 0.58]

0.43 [0.28; 0.54]

0.43 [0.29; 0.52]

0.47 [0.39; 0.61]

0.49 [0.39; 0.61]

0.43 [0.33; 0.65]

0.607

0.075

 

R20Hz, z-score

1.53 [0.84; 2.25]

1.60 [0.70; 2.18]

1.59 [0.32; 2.00]

1.64 [1.16; 2.68]

1.70 [1.04; 2.42]

1.62 [1.31; 2.37]

  

0.660

R5Hz, kPa/L/s

0.64 [0.38; 0.80]

0.60 [0.37; 0.75]

0.41 [0.35; 0.76]

0.59 [0.45; 0.88]

0.61 [0.46; 0.85]

0.51 [0.42; 1.16]

0.217

0.034

 

R5Hz, z-score

1.31 [0.51; 2.35]

1.10 [0.20; 2.56]

0.84 [0.15; 1.69]

1.32 [0.54; 2.46]

1.17 [0.54; 1.85]

1.17 [0.83; 3.77]

  

0.895

R5–20 Hz, kPa/L/s

0.17 [0.06; 0.22]

0.12 [0.05; 0.22]

0.07 [0.02; 0.23]

0.15 [0.07; 0.32]

0.14 [0.06; 0.19]

0.11 [0.07; 0.34]

0.049

0.278

 

R5–20 Hz, z-score

0.47 [0.04; 1.70]

0.33 [− 0.32; 1.42]

0.25 [− 0.36; 1.12]

0.55 [− 0.42; 1.57]

0.49 [− 0.49; 0.87]

0.62 [0.30; 2.00]

  

0.509

X5Hz, kPa/L/s

 − 0.24 [− 0.34; − 0.20]

 − 0.23 [− 0.33; − 0.19]

 − 0.16 [− 0.33; − 0.14]

 − 0.19 [− 0.31; − 0.15]

 − 0.20 [− 0.27; − 0.15]

 − 0.16 [− 0.31; − 0.12]

0.604

0.041

 

X5Hz, z-score

1.59 [0.58; 2.27]

1.48 [0.87; 1.67]

0.83 [0.67; 1.52]

0.88 [0.06; 1.72]

0.57 [0.16; 1.21]

0.76 [0.45; 2.11]

  

0.065

AX, kPa/L

1.34 [0.73; 2.76]

1.21 [0.68; 2.87]

0.39 [0.35; 2.97]

1.18 [0.50; 2.98]

1.16 [0.58; 2.06]

0.86 [0.41; 3.97]

0.328

0.016

 

AX, % z-score

0.92 [0.70; 1.91]

1.25 [0.45; 1.73]

0.84 [0.31; 2.02]

0.82 [0.21; 2.75]

0.76 [0.00; 1.28]

0.90 [0.51; 2.63]

  

0.253

eRIC model

RcentralRS, kPa/L/s

0.49 [0.32; 0.56]

0.44 [0.29; 0.52]

0.42 [0.29; 0.48]

0.49 [0.40; 0.60]

0.50 [0.40; 0.62]

0.41 [0.33; 0.63]

0.600

0.116

0.403

IRS × 100, kPa/L/s2

1.02 [0.90; 1.16]

0.91 [0.88; 1.01]

0.97 [0.90; 1.09]

0.97 [0.76; 1.15]

0.98 [0.75; 1.10]

0.95 [0.80; 1.13]

0.159

0.023

0.567

CpRS × 100, L/kPa

7.83 [5.57; 11.63]

7.15 [5.90; 12.48]

16.14 [5.51; 18.86]

8.80 [4.00; 15.28]

9.44 [7.00; 15.37]

11.05 [4.00; 16.34]

0.416

0.011

0.930

RperipheralRS, kPa/L/s

0.89 [0.68; 1.04]

0.71 [0.50; 0.94]

0.77 [0.62; 5.00]

1.00 [0.77; 1.67]

1.01 [0.66; 1.05]

0.67 [0.51; 1.14]

0.082

0.311

0.403

  1. VD is the anatomical volume of airways; AD denotes Autogenic Drainage
  2. $ The 7 children with airflow limitation who had a bronchodilator test had z-scores of FEV1 of − 2.72 [− 3.79; − 2.31] and FVC of − 1.55 [− 1.90; − 1.00] that have to be compared to the “After salbutamol” results
  3. ND denotes not done. Bold P values are those < 0.05
  4. The correlations between VD and height were highly significant (before physiotherapy: R = 0.91; after physiotherapy: R = 0.86, p < 0.0001 for both) justifying the normalisation